| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,220 | 5,764 | 4,573 | 12,083 | | Cost of Revenue | 1,574 | 1,952 | 1,421 | 1,281 | | | Gross Profit | 4,646 | 3,812 | 3,152 | 10,802 | | | Operating Expenses | | Research Development | 3,174 | 3,059 | 3,111 | 3,187 | | Selling General and Administrative | 2,635 | 2,400 | 2,294 | 2,858 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,163) | (1,647) | (2,253) | 4,757 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 31 | 61 | 125 | 221 | | Earnings Before Interest And Taxes | (1,132) | (1,586) | (2,128) | 4,978 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,132) | (1,586) | (2,128) | 4,978 | | Income Tax Expense | 1 | 1 | 3 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,133) | (1,587) | (2,131) | 4,978 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,133) | (1,587) | (2,131) | 4,978 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,133) | ($1,587) | ($2,131) | $4,978 |
|
0.11% Nasdaq 
0.01%
Income Statement
